09 Aug 2013 --- Novozymes has reported that first-half performance as expected, with full-year organic sales growth and EBIT margin outlook maintained. Organic sales growth was 6% (5% DKK, 6% LCY) compared with the first half of 2012. The gross margin improved by 0.7 percentage point. EBIT grew by 7%, and the EBIT margin increased by 0.4 percentage point to 24.6% compared with 1H 2012.
